Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19757 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Clara Lo. Beteiligte Einrichtung: Department of Paediatrics, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Benzoates, Pyrazoles, Hydrazines, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Paediatric immune thrombocytopenia treatment was revolutionized with the advent of the thrombopoietin mimetics romiplostim and eltrombopag. For eltrombopag, dosing recommendations have been based on patients' ages (with dose reductions for those with hepatic impairment and for some of East Asian ethnicity) and titrated based on platelet counts and adverse drug reactions. However, it is clear that identical eltrombopag dosing for paediatric patients can result in variable side effects and platelet counts, raising the question as to whether variable eltrombopag plasma concentrations are responsible for these differing drug responses. Commentary on: Dong et al. Exploratory study on the individualized application of eltrombopag in paediatric immune thrombocytopenia guided by therapeutic drug monitoring. Br J Haematol 2024; 205: 1930‐1937 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Stanford University, Stanford, California, USA.
ORCID-Profile: Clara Lo
Zitieren
APA
Lo, C. (2024). Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?. British Journal of Haematology. https://doi.org/10.1111/bjh.19757
Vancouver
Lo C. Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?. British Journal of Haematology. 2024. doi:10.1111/bjh.19757
BibTeX
@article{Lo2024,
author = {Lo, Clara},
title = {Is there a role for eltrombopag drug levels in paediatric immune thrombocytopenia management?},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19757}
}
EUVIMED